Filing Flows › Assembly Biosciences (ASMB) › Q2 2026 › vs Q2 2025
Assembly Biosciences (ASMB) Q2 2026 vs Q2 2025 (year over year)
Assembly Biosciences's revenue rose $3.7M (+39%) from $9.6M in Q2 2025 to $13.4M in Q2 2026.
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $13.4M | $9.6M | $3.7M | +39% |
| Other income, net | $2.5M | $895K | $1.6M | +178% |
| Net loss | $3.9M | $10.2M | −$6.3M | -62% |
| Costs & expenses | $19.7M | $20.7M | −$1.0M | -5% |
| Operating costs | $19.7M | $20.7M | −$1.0M | -5% |
| Research & development | $14.9M | $16.1M | −$1.2M | -7% |
| General & admin | $4.8M | $4.6M | $207K | +5% |
| Operating cash sources | $17.9M | $17.6M | $300K | +2% |
| Depreciation & amortization | $20K | $32K | −$12K | -38% |
| Share-based compensation | $2.4M | $834K | $1.6M | +190% |
| Cash used in operations | $15.5M | $16.8M | −$1.3M | -8% |
| Net loss absorbed | $3.9M | $10.2M | −$6.3M | -62% |
| Working capital & other | $14.1M | $7.4M | $6.6M | +89% |
Questions
How much did Assembly Biosciences's revenue grow year over year in Q2 2026?
Assembly Biosciences's revenue rose $3.7M (+39%) from $9.6M in Q2 2025 to $13.4M in Q2 2026.